DHI
25
-2
PLD
46
5
NRG
79
-3
SYK
53
-2
CF
51
-5
PPG
52
2
MAC
33
-11
PX
69
-3
CINF
58
2
ECL
45
-2
NVDA
61
-2
DHR
44
-2
KLAC
63
-2
LMT
59
2
PSA
51
5
LNC
60
7
CMS
67
9
RL
80
-3
ALLE
62
7
ILMN
45
-4
DHI
25
-2
PLD
46
5
NRG
79
-3
SYK
53
-2
CF
51
-5
PPG
52
2
MAC
33
-11
PX
69
-3
CINF
58
2
ECL
45
-2
NVDA
61
-2
DHR
44
-2
KLAC
63
-2
LMT
59
2
PSA
51
5
LNC
60
7
CMS
67
9
RL
80
-3
ALLE
62
7
ILMN
45
-4
Financhill
Back

Novonesis (Novozymes) B Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
58

NVZMY
Novonesis (Novozymes) B

Last Price:
$65.28
Seasonality Move:
5.54%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Novonesis (Novozymes) B Stock Forecast

  • Over the next 52 weeks, Novonesis (Novozymes) B has on average historically risen by 11.1% based on the past 19 years of stock performance.
  • Novonesis (Novozymes) B has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
  • Is Novonesis (Novozymes) B Stock Undervalued?
    The current Novonesis (Novozymes) B [NVZMY] share price is $67.12. The Score for NVZMY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • NVZMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Novonesis (Novozymes) B Stock Go Up Next Year?

  • Over the next 52 weeks, Novonesis (Novozymes) B has on average historically risen by 11.1% based on the past 19 years of stock performance.

Novonesis (Novozymes) B Stock Rating

Buy
58
Novonesis (Novozymes) B (NVZMY) is a Buy

Is Novonesis (Novozymes) B overpriced?

  • Novonesis (Novozymes) B has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%

Novonesis (Novozymes) B Stock Price History

Is NVZMY stock going to rise?

  • The current trend is moderately bullish and NVZMY is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Chemicals
Sector:
Materials
Type:
stock
Website:
novozymes.com

52-Week Data

52-Week High:
72.50
52-Week Low:
53.95

Prediction Charts

Market Cap:
31.3B
Price in USD:
67.12
Volume:
53.7K
Beta:
0.87

Technical Analysis

SMA50:
61.07
SMA100:
58.91
SMA200:
61.65
52-Wk Change:
11.13%

Stock Predictions

  • Is Novonesis (Novozymes) B stock public?
    Yes, Novonesis (Novozymes) B is a publicly traded company.
  • What is the Novonesis (Novozymes) B stock quote today?
    The Novonesis (Novozymes) B stock price is 67.12 USD today.
  • How to buy Novonesis (Novozymes) B stock online?
    You can buy Novonesis (Novozymes) B shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 60.80 62.00 64.15 60.00
Apr-23 62.45 62.29 63.38 61.73
Apr-24 63.81 63.16 64.72 60.80
Apr-25 63.93 63.91 64.33 60.75
Apr-28 61.39 62.99 64.37 60.67
Apr-29 62.71 63.53 65.00 62.67
Apr-30 63.53 64.91 66.46 63.53
May-1 62.76 66.04 67.07 62.50
May-2 64.46 65.70 67.50 64.21
May-5 66.59 65.50 66.59 64.60
May-6 63.77 65.19 65.43 62.90
May-7 65.09 64.66 65.65 62.95
May-8 66.65 67.08 67.94 65.21
May-9 67.99 67.12 68.00 66.13

Novonesis (Novozymes) B Earnings

Data Unavailable

Novonesis (Novozymes) B Forecast Revenue Growth

Data Unavailable

* Novonesis (Novozymes) B stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.